CLEVELAND, Sept. 17, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today
Growth Capitalist (https://growthcapitalist.com/2018/09/viewray-announces-equity-inducement-awards-under-nasdaq-listing-rule-5635c4/)
CLEVELAND, Sept. 17, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today